ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LFWD vs HSCS // REVENUE GROWTH (YOY)

Lifeward Ltd. (NASDAQ) VS. HeartSciences Inc. (NASDAQ) • 15-METRIC TALLY: LFWD 2 — HSCS 3
▲ REVENUE GROWTH (YOY) LEADER: HSCS
revenue-growth
-17.60%
revenue-growth
-0.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFWD VS. HSCS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LFWD HSCS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 59.10% +36.90 LFWD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE -17.60% -0.70% -16.90 HSCS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 LFWD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 53.1 -9.00 HSCS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.7M $17.5M -$749.3K HSCS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LFWD REV HSCS REV LFWD GROSS % HSCS GROSS % LFWD FCF HSCS FCF
FY 2025 $1.4M $4.3K 98.0% 59.1% -$16.8M -$7.4M
FY 2024 $1.7M $4.3K 98.0% 56.8% -$21.7M -$7.4M
FY 2023 $435.0K $18.6K — — -$20.7M -$6.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFWD // BETA —
HSCS // BETA —